$1.65
0.02971.83%
Últ. Act.: Oct 9, 9:56 AM
$1.61
-0.01-0.62%
OS Therapies (OSTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.23 | $-0.19 | $-0.16 | $-0.13 |
| Actual | $-0.20 | $-0.27 | $-0.41 | $-0.21 |
| Surprise | +13.0% | -42.1% | -156.3% | -61.5% |
| Revenue | ||||
| Estimate | $204400 | $242750 | — | $27.5M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | — | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.12 | $-0.15 | $-0.04 |
| Revenue | |||
| Consensus | $600000 | $31.0M | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 17, 2026 | $-0.20 | $-0.23 | 13.0 % |
| Q1 | May 18, 2026 | $-0.27 | $-0.19 | -42.1 % |
| Q4 | Mar 31, 2026 | $-0.41 | $-0.16 | -156.3 % |
| Q3 | Nov 17, 2025 | $-0.21 | $-0.13 | -61.5 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 17, 2026 | $0 | $204.40K | -100.0 % |
| Q1 | May 18, 2026 | $0 | $242.75K | -100.0 % |
| Q3 | Nov 17, 2025 | $0 | $27.50M | -100.0 % |
| Q3 | Nov 15, 2024 | $0 | $150.00K | -100.0 % |